MetaCap

Becton Dickinson and Company (BDX)

NYSE: BDXHealth CareMedical/Dental InstrumentsUSD

212.78+0.10 (+0.05%)

At close: Nov 20, 4:00 PM ET · Delayed 15 min

BDX stock chart

Technical analysis

Key statistics

All statistics
Market cap
$57.96B
Dividend yield
1.99% ($0.00)
Ex-dividend date
Sep 9, 2026
52-week range
140.11 – 220.36
Day range
211.32 – 216.52
Volume / Avg
1.96M / 1.80M
Beta
—

52-week range

$140.11$220.36

BDX stock today

On Nov 20, BDX ended the session at $212.78, adding $0.10 (0.05%), versus the S&P 500's 3.70% decline. At this level, BDX sits near the top of its 52-week range of $140.11 to $220.36: 3.4% below the high, set on Nov 16, 2026 and 51.9% above the low. BDX is up 39.5% year to date, outperforming the S&P 500 (+1.2%). Over the past 12 months, the stock has gained 40.4%.

At 42.1x trailing earnings, Becton Dickinson trades above the peer-group median of 31.2x. Its forward P/E of 15.0x is lower than the trailing multiple, which means analysts expect earnings to rise over the next year.

Summary generated from market data by MetaCap's automated system. Methodology

About Becton Dickinson

Company profile

Becton, Dickinson and Company develops, manufactures, and sells medical supplies, devices, laboratory equipment, and diagnostic products for healthcare institutions, physicians, life science researchers, clinical laboratories, pharmaceutical industry, and the general public worldwide. It operates through Medical Essentials, Connected Care, BioPharma Systems, Interventional and Life Sciences segments. It provides peripheral intravenous (IV) and advanced peripheral catheters, central lines, acute dialysis catheters, vascular access technology, vascular care and preparation products, needle-free IV connectors and extensions sets, closed-system drug transfer devices, hazardous drug detections, hypodermic syringes and needles, anesthesia needles and trays, enteral syringes, and sharps disposal systems; IV medication safety and infusion therapy delivery systems, medication compounding workflow system, automated medication dispensing and supply management systems, informatics and analytics and pharmacy automation system, and medication inventory optimization and tracking system; hemodynamic monitoring system; and prefillable drug delivery systems.

Industry
Medical/Dental Instruments
CEO
Mr. Thomas E. Polen Jr.
Headquarters
Franklin Lakes, NJ
Employees
60,000
Website
bd.com

Financial highlights

Full financials

In fiscal 2025, Becton Dickinson generated $21.84 billion in revenue, up 8.2% from fiscal 2024, its 3rd consecutive year of revenue growth. Net income was $1.68 billion (-1.6% year over year), for a net margin of 7.7% versus a median of 8.4% in the prior 5 years. Gross margin was 45.4% (up from 45.2%) and operating margin 11.8%.

Becton Dickinson annual revenue, net income and EPS
Fiscal yearFY 2025FY 2024FY 2023FY 2022FY 2021
Revenue$21.84B$20.18B$19.37B$18.87B$19.13B
Growth+8.24%+4.16%+2.66%-1.36%+19.02%
Net income$1.68B$1.71B$1.48B$1.78B$2.09B
EPS (diluted)$5.82$5.86$4.94$5.88$6.85

Analyst forecast

Forecast

Consensus (16 analysts)

buy

Avg. price target

$226.14+6.28%

  • Strong buy 1
  • Buy 8
  • Hold 6
  • Sell 0
  • Strong sell 1

Target range

Low $195.00High $242.00

Ratings and targets reflect third-party analyst opinions, not MetaCap recommendations.

Earnings

Earnings history
Last reported (Sep/2026)
Nov 5, 2026
EPS actual vs est.
$4.15 vs $4.06
Surprise
+2.22%

Dividends

Dividend history
Annual dividend
$0.00
Last payment
$1.05
Ex-dividend date
Sep 9, 2026

BDX news

All BDX news

Becton Dickinson peers

Health Care sector
BDX peer companies
CompanyPrice% ChgMarket capCompare
BSXBoston Scientific Corporation41.98-2.35%$60.85Bvs BDX
MDLNMedline Inc. Class A37.04-2.11%$48.75Bvs BDX
RMDResMed Inc.235.63-0.53%$33.14Bvs BDX
DXCMDexCom Inc.79.32-1.08%$29.58Bvs BDX
WSTWest Pharmaceutical Services Inc.390.30-1.61%$27.19Bvs BDX
MMM3M Company177.99-0.27%$91.97Bvs BDX
SOLVSolventum Corporation84.50-1.52%$14.36Bvs BDX
GKOSGlaukos Corporation237.31-0.33%$14.05Bvs BDX

Indexes, lists and sector

Becton Dickinson stock FAQ

What is Becton Dickinson's stock price today?

BDX last traded at $212.78 as of Nov 20, 4:00 PM EST, up 0.05% on the day. Prices are delayed at least 15 minutes.

Does Becton Dickinson pay a dividend?

Yes. Becton Dickinson pays $0.00 per share annually, a 1.99% yield. The most recent dividend of $1.05 had an ex-dividend date of Sep 9, 2026.

What is BDX's P/E ratio?

BDX trades at a trailing P/E ratio of 42.05 and a forward P/E of 14.96, compared with a median of 31.2 for its closest peers.

Is Becton Dickinson in the S&P 500?

Yes. Becton Dickinson (BDX) is a constituent of the S&P 500 index.

Who is Becton Dickinson's CEO?

Mr. Thomas E. Polen Jr. is the chief executive officer of Becton Dickinson and Company, which has about 60,000 employees.

Has BDX ever split its stock?

Yes. The most recent BDX stock split was a 1272-for-1000 split on Feb 10, 2026, one of 6 splits on record.

What is the BDX 52-week high?

The 52-week high for BDX is $220.36 and the 52-week low is $140.11. The stock is currently 3.4% below its high.

Compare BDX